While reporting financial results for the second quarter on Wednesday, Biogen Inc. (BIIB) raised its adjusted earnings and revenue guidance for the full-year 2022, based on better-than-expected topline performance and continued cost management.
from RTT - Earnings https://ift.tt/ioZGh9y
via IFTTT
No comments:
Post a Comment